Cargando…
Spinal Cord Impairment in Anti-Mag Neuropathy: Evidence from Somatosensory Evoked Potentials
Anti-Myelin Associated Glycoprotein (anti-MAG) neurological involvement classically manifests as a peripheral neuropathy with prominent sensitive symptoms. We describe a case report of a patient with positive anti-MAG antibodies presenting with clinical and neurophysiological evidence of spinal cord...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287849/ https://www.ncbi.nlm.nih.gov/pubmed/32397154 http://dx.doi.org/10.3390/brainsci10050282 |
_version_ | 1783545144783405056 |
---|---|
author | Boscarino, Marilisa Lanzone, Jacopo Ricci, Lorenzo Tombini, Mario Di Lazzaro, Vincenzo Assenza, Giovanni |
author_facet | Boscarino, Marilisa Lanzone, Jacopo Ricci, Lorenzo Tombini, Mario Di Lazzaro, Vincenzo Assenza, Giovanni |
author_sort | Boscarino, Marilisa |
collection | PubMed |
description | Anti-Myelin Associated Glycoprotein (anti-MAG) neurological involvement classically manifests as a peripheral neuropathy with prominent sensitive symptoms. We describe a case report of a patient with positive anti-MAG antibodies presenting with clinical and neurophysiological evidence of spinal cord impairment. A 69-year-old woman came to our attention with subacute onset of dysesthesias at lower limbs and ataxia. Blood routine tests and hematological work-up led to a diagnosis of monoclonal gammopathy of undetermined significance. High titers of anti-MAG antibodies was revealed (34,594.70 BTU/mL, normal range 0–1000). Nerve conduction studies (NCS) ruled out a polyneuropathy at lower limbs. Somatosensory evoked potentials (SSEPs) showed prolonged central conduction time (CTT) at lower limbs, suggesting a dorsal column damage. Brain and spinal cord Magnetic Resonance Imaging (MRI) did not reveal any significant lesion. Analysis of cerebrospinal fluid (CSF) evidenced an albumin-cytologic dissociation. She was treated with corticosteroids with temporary remission of sensory symptoms and normalization of CTT. Subsequently, she developed a multineuropathy which was successfully treated with Rituximab. We discuss the potential role of anti-MAG antibodies in the pathophysiology of dorsal column impairment and the clinical usefulness of SSEPs in monitoring the evolution of anti-MAG neuropathy. |
format | Online Article Text |
id | pubmed-7287849 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72878492020-06-15 Spinal Cord Impairment in Anti-Mag Neuropathy: Evidence from Somatosensory Evoked Potentials Boscarino, Marilisa Lanzone, Jacopo Ricci, Lorenzo Tombini, Mario Di Lazzaro, Vincenzo Assenza, Giovanni Brain Sci Case Report Anti-Myelin Associated Glycoprotein (anti-MAG) neurological involvement classically manifests as a peripheral neuropathy with prominent sensitive symptoms. We describe a case report of a patient with positive anti-MAG antibodies presenting with clinical and neurophysiological evidence of spinal cord impairment. A 69-year-old woman came to our attention with subacute onset of dysesthesias at lower limbs and ataxia. Blood routine tests and hematological work-up led to a diagnosis of monoclonal gammopathy of undetermined significance. High titers of anti-MAG antibodies was revealed (34,594.70 BTU/mL, normal range 0–1000). Nerve conduction studies (NCS) ruled out a polyneuropathy at lower limbs. Somatosensory evoked potentials (SSEPs) showed prolonged central conduction time (CTT) at lower limbs, suggesting a dorsal column damage. Brain and spinal cord Magnetic Resonance Imaging (MRI) did not reveal any significant lesion. Analysis of cerebrospinal fluid (CSF) evidenced an albumin-cytologic dissociation. She was treated with corticosteroids with temporary remission of sensory symptoms and normalization of CTT. Subsequently, she developed a multineuropathy which was successfully treated with Rituximab. We discuss the potential role of anti-MAG antibodies in the pathophysiology of dorsal column impairment and the clinical usefulness of SSEPs in monitoring the evolution of anti-MAG neuropathy. MDPI 2020-05-08 /pmc/articles/PMC7287849/ /pubmed/32397154 http://dx.doi.org/10.3390/brainsci10050282 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Boscarino, Marilisa Lanzone, Jacopo Ricci, Lorenzo Tombini, Mario Di Lazzaro, Vincenzo Assenza, Giovanni Spinal Cord Impairment in Anti-Mag Neuropathy: Evidence from Somatosensory Evoked Potentials |
title | Spinal Cord Impairment in Anti-Mag Neuropathy: Evidence from Somatosensory Evoked Potentials |
title_full | Spinal Cord Impairment in Anti-Mag Neuropathy: Evidence from Somatosensory Evoked Potentials |
title_fullStr | Spinal Cord Impairment in Anti-Mag Neuropathy: Evidence from Somatosensory Evoked Potentials |
title_full_unstemmed | Spinal Cord Impairment in Anti-Mag Neuropathy: Evidence from Somatosensory Evoked Potentials |
title_short | Spinal Cord Impairment in Anti-Mag Neuropathy: Evidence from Somatosensory Evoked Potentials |
title_sort | spinal cord impairment in anti-mag neuropathy: evidence from somatosensory evoked potentials |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287849/ https://www.ncbi.nlm.nih.gov/pubmed/32397154 http://dx.doi.org/10.3390/brainsci10050282 |
work_keys_str_mv | AT boscarinomarilisa spinalcordimpairmentinantimagneuropathyevidencefromsomatosensoryevokedpotentials AT lanzonejacopo spinalcordimpairmentinantimagneuropathyevidencefromsomatosensoryevokedpotentials AT riccilorenzo spinalcordimpairmentinantimagneuropathyevidencefromsomatosensoryevokedpotentials AT tombinimario spinalcordimpairmentinantimagneuropathyevidencefromsomatosensoryevokedpotentials AT dilazzarovincenzo spinalcordimpairmentinantimagneuropathyevidencefromsomatosensoryevokedpotentials AT assenzagiovanni spinalcordimpairmentinantimagneuropathyevidencefromsomatosensoryevokedpotentials |